Abingworth LLP E Ffector Therapeutics, Inc. Transaction History
Abingworth LLP
- $301 Million
- Q4 2022
A detailed history of Abingworth LLP transactions in E Ffector Therapeutics, Inc. stock. As of the latest transaction made, Abingworth LLP holds 4,822,114 shares of EFTR stock, worth $192,884. This represents 0.69% of its overall portfolio holdings.
Number of Shares
4,822,114
Previous 4,822,114
-0.0%
Holding current value
$192,884
Previous $2.73 Million
24.07%
% of portfolio
0.69%
Previous 0.93%
Shares
1 transactions
Others Institutions Holding EFTR
# of Institutions
6Shares Held
6.53MCall Options Held
0Put Options Held
0-
Oup Management Co., LLC1.03MShares$41,0271.38% of portfolio
-
Evolution Capital Management LLC Crystal Bay, NV528KShares$21,1151.04% of portfolio
-
Parallel Advisors, LLC67.7KShares$2,7090.0% of portfolio
-
Blackstone Inc New York, NY52.3KShares$2,0930.0% of portfolio
-
Resolute Financial, LLC31KShares$1,2400.01% of portfolio
About eFFECTOR Therapeutics, Inc.
- Ticker EFTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,452,800
- Market Cap $1.66M
- Description
- eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...